Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study

MLA

Martin Nicol, et al. “Prognostic Value of Soluble ST2 in AL and TTR Cardiac Amyloidosis: A Multicenter Study.” Frontiers in Cardiovascular Medicine, vol. 10, Aug. 2023. EBSCOhost, https://doi.org/10.3389/fcvm.2023.1179968.

APA

Martin Nicol, Giuseppe Vergaro, Thibaud Damy, Mounira Kharoubi, Mathilde Baudet, Elena Sofia Canuti, Alberto Aimo, Vincenzo Castiglione, Michele Emdin, Bruno Royer, Stephanie Harel, Alain Cohen-Solal, Bertrand Arnulf, & Damien Logeart. (2023). Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study. Frontiers in Cardiovascular Medicine, 10. https://doi.org/10.3389/fcvm.2023.1179968

Chicago

Martin Nicol, Giuseppe Vergaro, Thibaud Damy, Mounira Kharoubi, Mathilde Baudet, Elena Sofia Canuti, Alberto Aimo, et al. 2023. “Prognostic Value of Soluble ST2 in AL and TTR Cardiac Amyloidosis: A Multicenter Study.” Frontiers in Cardiovascular Medicine 10 (August). doi:10.3389/fcvm.2023.1179968.